DE1617839A1 - Methode zur Kontrazeption - Google Patents
Methode zur KontrazeptionInfo
- Publication number
- DE1617839A1 DE1617839A1 DE19671617839 DE1617839A DE1617839A1 DE 1617839 A1 DE1617839 A1 DE 1617839A1 DE 19671617839 DE19671617839 DE 19671617839 DE 1617839 A DE1617839 A DE 1617839A DE 1617839 A1 DE1617839 A1 DE 1617839A1
- Authority
- DE
- Germany
- Prior art keywords
- active ingredient
- administered
- effect
- hydroxyprogesterone
- ovulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 23
- 239000004480 active ingredient Substances 0.000 claims description 24
- 239000000583 progesterone congener Substances 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 12
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 230000016087 ovulation Effects 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 229960002899 hydroxyprogesterone Drugs 0.000 claims description 8
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 5
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical group C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 claims description 4
- 229960002903 benzyl benzoate Drugs 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 238000010494 dissociation reaction Methods 0.000 claims description 4
- 230000005593 dissociations Effects 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- 239000008159 sesame oil Substances 0.000 claims description 4
- 235000011803 sesame oil Nutrition 0.000 claims description 4
- 230000003152 gestagenic effect Effects 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- 230000002254 contraceptive effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 230000027758 ovulation cycle Effects 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- -1 keto, amino Chemical group 0.000 description 3
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- CAFOMEFFALHXPZ-IZPLOLCNSA-N (8r,9s,10r,13s,14s,17s)-13-methyl-1,2,3,6,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-ol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 CAFOMEFFALHXPZ-IZPLOLCNSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 206010047998 Withdrawal bleed Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 231100000546 inhibition of ovulation Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000003903 lactic acid esters Chemical class 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001072 progestational effect Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-M undecanoate Chemical compound CCCCCCCCCCC([O-])=O ZDPHROOEEOARMN-UHFFFAOYSA-M 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC040583 | 1967-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1617839A1 true DE1617839A1 (de) | 1971-04-08 |
Family
ID=7435756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19671617839 Pending DE1617839A1 (de) | 1967-04-19 | 1967-04-19 | Methode zur Kontrazeption |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3758687A (enrdf_load_stackoverflow) |
| BE (1) | BE713958A (enrdf_load_stackoverflow) |
| DE (1) | DE1617839A1 (enrdf_load_stackoverflow) |
| FR (1) | FR8061M (enrdf_load_stackoverflow) |
| GB (2) | GB1231412A (enrdf_load_stackoverflow) |
| NL (1) | NL6805612A (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4171358A (en) * | 1974-04-19 | 1979-10-16 | Eli Lilly And Company | Novel contraceptive method |
| US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5433219A (en) * | 1992-09-23 | 1995-07-18 | Spery; Nanette S. | Receptive condom assembly |
| AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
| US9844558B1 (en) | 2015-04-30 | 2017-12-19 | Amag Pharmaceuticals, Inc. | Methods of reducing risk of preterm birth |
| US10556922B2 (en) | 2015-09-29 | 2020-02-11 | Amag Pharmaceuticals, Inc. | Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate |
-
1967
- 1967-04-19 DE DE19671617839 patent/DE1617839A1/de active Pending
-
1968
- 1968-04-19 FR FR148725A patent/FR8061M/fr not_active Expired
- 1968-04-19 NL NL6805612A patent/NL6805612A/xx unknown
- 1968-04-19 BE BE713958D patent/BE713958A/xx unknown
- 1968-04-19 GB GB1231412D patent/GB1231412A/en not_active Expired
- 1968-04-19 GB GB0714/71A patent/GB1253500A/en not_active Expired
-
1971
- 1971-04-20 US US00135814A patent/US3758687A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR8061M (enrdf_load_stackoverflow) | 1970-07-06 |
| BE713958A (enrdf_load_stackoverflow) | 1968-10-21 |
| NL6805612A (enrdf_load_stackoverflow) | 1968-10-21 |
| US3758687A (en) | 1973-09-11 |
| GB1231412A (enrdf_load_stackoverflow) | 1971-05-12 |
| GB1253500A (en) | 1971-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3916112C2 (enrdf_load_stackoverflow) | ||
| EP0770388B1 (de) | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene | |
| EP0499348B1 (de) | Ovulationshemmendes Mittel zur hormonalen Kontrazeption | |
| DE69316747T3 (de) | Verhuetungsverfahren mittels kompetitive progestronantagonisten und aehnliche neue verbindungen | |
| DE68917219T2 (de) | Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren. | |
| EP1474119A1 (de) | Verwendung von selektiv den estrogenrezeptor beta modulierenden phytoestrogenhaltigen extrakten | |
| DE2661002C2 (enrdf_load_stackoverflow) | ||
| DE4224534A1 (de) | Ovulationshemmendes Mittel zur hormonalen Kontrazeption | |
| DE3836862A1 (de) | Mittel zur transdermalen applikation von steroidhormonen | |
| DE2818586C2 (enrdf_load_stackoverflow) | ||
| DE1617839A1 (de) | Methode zur Kontrazeption | |
| DE2431704A1 (de) | Stufenkombinationspraeparate per kontrazeption | |
| CH643738A5 (en) | Highly concentrated pharmaceutical steroid products | |
| EP1347764A2 (de) | Gelzusammensetzung und transskrotale applikation einer zusammensetzung zur behandlung von hypogonadismus | |
| DE102004019743B4 (de) | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens | |
| DE2529523A1 (de) | Neue mittel und neue methoden zur behandlung klimakterischer ausfallserscheinungen | |
| DD299619A5 (de) | Verwendung einer zusammensetzung zur verhinderung von prostatakrebs | |
| DE1617837A1 (de) | Methode zur Kontrazeptien | |
| WO1997041865A1 (de) | Topische penile androgen-applikation zur behandlung der erektilen dysfunktion | |
| EP0322352B1 (de) | Verwendung von Antigestagenen zur Herstellung von Arzneimitteln | |
| DE934665C (de) | Verfahren zur Herstellung von Loesungen von Steroiden | |
| DE102019115343A1 (de) | Vaginalring für die hormonelle Kontrazeption | |
| DE4216004A1 (de) | Verwendung kompetitiver Progesteronantagonisten | |
| DE1922005A1 (de) | Mittel und Methode zur Kontrazeption | |
| WO1995022332A1 (de) | Mittel und verfahren zur postmenopausalen hormonsubstitution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHN | Withdrawal |